- Home
- KTCC vs LSB Comparison
KTCC vs LSB Comparison
Compare KTCC & LSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTCC
- LSB
- Stock Information
- Founded
- KTCC 1969
- LSB 2002
- Country
- KTCC United States
- LSB China
- Employees
- KTCC N/A
- LSB N/A
- Industry
- KTCC Electrical Products
- LSB
- Sector
- KTCC Technology
- LSB
- Exchange
- KTCC Nasdaq
- LSB NYSE
- Market Cap
- KTCC 34.0M
- LSB 32.2M
- IPO Year
- KTCC N/A
- LSB N/A
- Fundamental
- Price
- KTCC $2.39
- LSB $1.38
- Analyst Decision
- KTCC
- LSB
- Analyst Count
- KTCC 0
- LSB 0
- Target Price
- KTCC N/A
- LSB N/A
- AVG Volume (30 Days)
- KTCC 25.2K
- LSB 34.3K
- Earning Date
- KTCC 05-06-2025
- LSB 12-19-2024
- Dividend Yield
- KTCC N/A
- LSB N/A
- EPS Growth
- KTCC N/A
- LSB N/A
- EPS
- KTCC N/A
- LSB N/A
- Revenue
- KTCC $514,394,000.00
- LSB $79,415,311.00
- Revenue This Year
- KTCC N/A
- LSB $39.33
- Revenue Next Year
- KTCC N/A
- LSB $75.61
- P/E Ratio
- KTCC N/A
- LSB N/A
- Revenue Growth
- KTCC N/A
- LSB N/A
- 52 Week Low
- KTCC $2.21
- LSB $1.50
- 52 Week High
- KTCC $6.14
- LSB $11.20
- Technical
- Relative Strength Index (RSI)
- KTCC 39.50
- LSB 28.40
- Support Level
- KTCC $2.25
- LSB $1.50
- Resistance Level
- KTCC $2.40
- LSB $1.79
- Average True Range (ATR)
- KTCC 0.13
- LSB 0.23
- MACD
- KTCC 0.01
- LSB -0.08
- Stochastic Oscillator
- KTCC 36.73
- LSB 5.80
About KTCC Key Tronic Corporation
Key Tronic Corp is an electronic manufacturing service provider. The company provides electronic manufacturing services to original equipment manufacturers in the United States and globally. Its primary services include integrated electronic and mechanical engineering, precision plastic molding, sheet metal fabrication, printed circuit board (PCB) and complete product assembly, component selection, sourcing and procurement, logistics, and new product testing and production. The firm derives a majority of its revenue from the United States.
About LSB LAKESHORE BIOPHARMA CO LTD
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.